ANTX AN2 Therapeutics, Inc.

NASDAQ
$4.47

AN2 Therapeutics, Inc. (ANTX) is expected to report earnings on February 8, 2027, after the market close.

AN2 Therapeutics Reported Earnings
Monday, November 9, 2026 · 7:30 AM ET
Earnings Date
Feb 8
Monday · 4:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About AN2 Therapeutics, Inc.

AN2 Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on developing treatments for rare, chronic and serious infectious diseases with high unmet needs. AN2 Therapeutics Inc. is based in MENLO PARK, Calif.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.